Center for Rheumatology and Spine Diseases

Medicine & Life Sciences

1. Rheumatoid Arthritis 100%
2. Systemic Lupus Erythematosus 31%
3. Magnetic Resonance Imaging 28%
4. Psoriatic Arthritis 27%
5. Joints 25%
6. Synovitis 21%
7. Tumor Necrosis Factor Inhibitors 21%
8. Rheumatology 18%
9. Inflammation 18%
10. Arthritis 17%
11. Antirheumatic Agents 17%
12. Cohort Studies 16%
13. Therapeutics 15%
14. Registries 13%
15. Sacroiliac Joint 12%
16. Rheumatic Diseases 12%
17. Ankylosing Spondylitis 12%
18. Randomized Controlled Trials 11%
19. Tumor Necrosis Factor-alpha 11%
20. Exercise 11%
21. Adalimumab 11%
22. Denmark 11%
23. Methotrexate 10%
24. Rheumatologists 10%
25. Infliximab 9%
26. Cytokines 9%
27. Autoantibodies 9%
28. Anti-Citrullinated Protein Antibodies 9%
29. Bone and Bones 8%
30. Ultrasonography 8%
31. Pain 8%
32. Antibodies 8%
33. Serum 8%
34. Radiography 7%
35. Systematic Reviews 7%
36. Placebos 7%
37. Low Back Pain 7%
38. Edema 7%
39. Autoimmune Diseases 7%
40. Hematopoietic Stem Cell Transplantation 7%
41. Gout 7%
42. Biomarkers 7%
43. B-Lymphocytes 7%
44. Rituximab 7%
45. Health Care Outcome Assessment 7%
46. Tenosynovitis 7%
47. Population 6%
48. Interleukin-6 6%
49. Systemic Scleroderma 6%
50. Pharmaceutical Preparations 6%
51. Hand 6%
52. Fibromyalgia 6%
53. T-Lymphocytes 6%
54. Joint Diseases 6%
55. Clinical Trials 6%
56. Fatigue 6%
57. Biological Products 6%
58. Spine 6%
59. Granulomatosis with Polyangiitis 6%
60. Observational Studies 6%
61. Lupus Nephritis 6%
62. Psoriasis 5%
63. Anti-Idiotypic Antibodies 5%
64. Cross-Sectional Studies 5%
65. C-Reactive Protein 5%
66. Metacarpophalangeal Joint 5%
67. Abatacept 5%
68. Patient Reported Outcome Measures 5%
69. Periodontitis 5%
70. Mortality 5%
71. Confidence Intervals 5%
72. Wrist 5%
73. Glucocorticoids 5%
74. Health 5%
75. Osteoarthritis 5%
76. Etanercept 5%
77. Giant Cell Arteritis 5%
78. Protein-Arginine Deiminases 5%
79. Multicenter Studies 5%
80. Multiple Sclerosis 5%
81. Osteitis 5%
82. Interferons 5%